Related Experiment Video
Updated: Apr 17, 2026

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
Published on: May 16, 2025
The natural history of pediatric-onset discoid lupus erythematosus
Lisa M Arkin1, Leah Ansell1, Alfred Rademaker2
1Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Insights
Pediatric discoid lupus erythematosus (DLE) can progress to systemic lupus erythematosus (SLE) in a significant number of cases, particularly within the first year of diagnosis. Monitoring is crucial for early detection and management of potential SLE development.
Area of Science:
- Pediatric rheumatology
- Dermatology
- Immunology
Background:
- Pediatric discoid lupus erythematosus (DLE) is a rare condition.
- The likelihood of DLE progressing to systemic lupus erythematosus (SLE) in children is not well-established.
Purpose of the Study:
- To investigate the risk of pediatric DLE transforming into SLE.
- To describe the clinical and laboratory characteristics of pediatric DLE patients who develop SLE.
Main Methods:
- Retrospective analysis of 40 pediatric patients diagnosed with DLE.
- Review of medical records to identify progression to SLE and associated phenotypes.
Main Results:
- 15% of patients had concurrent SLE at DLE diagnosis.
- 26% of the remaining patients progressed to meet SLE criteria.
- 44% developed laboratory abnormalities suggestive of SLE.
- Progression to SLE occurred most frequently within the first year post-DLE diagnosis, with an average age of 11 years.
- Most SLE cases presented with mucocutaneous manifestations and laboratory findings, without significant end-organ damage within 5 years.
Conclusions:
- Pediatric DLE carries a substantial risk of progression to SLE.
- Progression to SLE in pediatric DLE patients may be associated with a milder systemic disease phenotype.
- Close monitoring for SLE development is essential for all pediatric DLE patients, especially during the initial year after diagnosis.
Background:
Pediatric discoid lupus erythematosus (DLE) is rare. The risk of progression to systemic lupus erythematosus (SLE) is uncertain.
Objective:
We sought to determine the risk of progression of pediatric DLE to SLE and to characterize its phenotype.
Methods:
This was a retrospective review of 40 patients with DLE.
Results:
Six (15%) of 40 patients presented with DLE as a manifestation of concurrent SLE. Of the remaining 34, 9 (26%) eventually met SLE criteria and 15 (44%) developed laboratory abnormalities without meeting SLE criteria. Only 10 (29%) maintained skin-limited disease. The average age at progression to SLE was 11 years, with greatest risk in the first year after DLE diagnosis. Most (89%) patients with SLE met diagnostic criteria with mucocutaneous disease (discoid lesions, malar rash, oral and nasal ulcers, photosensitivity), positive antibodies, and/or cytopenia without developing end-organ damage over 5 years of median follow-up.
Limitations:
The study was retrospective.
Conclusions:
In pediatric patients, DLE carries a significant risk of progression to SLE but may predict a milder phenotype of systemic disease. All patients require careful monitoring for SLE, particularly within the first year of diagnosis.
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Degenerative Disc Disease I: Introduction
Pharmacokinetics in Pediatric Patients: Drug Excretion
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...

